IRF9 anticorps (N-Term)
Aperçu rapide pour IRF9 anticorps (N-Term) (ABIN2797511)
Antigène
Voir toutes IRF9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 75-104, N-Term
-
Fonction
- Rabbit Anti-Mouse IRF9 (N-term) Antibody
-
Immunogène
- This IRF9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 75-104 amino acids from the N-terminal region of human IRF9.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
-
Western Blot, Immunohistochemistry, Immunofluorescence
Recommended Dilutions
WB: 1:1000, IHC: 1:10-50, IF: 1:10-50IRF9 Antibody (N-term) . -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.280 mg/mL
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- 2-8°C (short-term), -20°C (long-term)
-
-
- IRF9 (Interferon Regulatory Factor 9 (IRF9))
-
Autre désignation
- IRF9
-
Sujet
-
Target Description: IRF9 is a transcription regulatory factor that mediates signaling by type I IFNs (IFN-alpha and IFN-beta). Following type I IFN binding to cell surface receptors, Jak kinases (TYK2 and JAK1) are activated, leading to tyrosine phosphorylation of STAT1 and STAT2. The phosphorylated STATs dimerize, associate with IRF9/ISGF3G to form a complex termed ISGF3 transcription factor, that enters the nucleus. ISGF3 binds to the IFN stimulated response element (ISRE) to activate the transcription of interferon stimulated genes, which drive the cell in an antiviral state.
Gene Symbol: IRF9
-
Poids moléculaire
- 43696 Da
-
ID gène
- 10379
-
UniProt
- Q00978
-
Pathways
- Signalistation JAK/STAT, Interferon-gamma Pathway, Hepatitis C
Antigène
-